Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
第一作者:
G V,Scagliotti
第一单位:
Universitá di Torino, Dipartimento di Scienze Cliniche e Biologiche, Ospedale S. Luigi Gonzaga, Orbassano/Torino, Italy.
作者:
医学主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);癌, 鳞状细胞(Carcinoma, Squamous Cell);疾病恶化(Disease Progression);依托泊甙(Etoposide);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);血液病(Hematologic Diseases);人类(Humans);异环磷酰胺(Ifosfamide);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);放射疗法, 辅助(Radiotherapy, Adjuvant);重组蛋白质类(Recombinant Proteins);存活率(Survival Rate)
DOI
10.1007/s002800050527
PMID
8823499
发布时间
2019-08-30
- 浏览20
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



